TP53 and breast ductal adenocarcinoma: Other studies have also applied radiomics based on different imaging techniques to predict the expression status of p53 in epithelial ovarian cancer (64), endometrial carcinoma (65), esophageal squamous cell carcinoma (66), and breast ductal carcinoma (67).